|
Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial. |
|
|
|
Honoraria - Amgen; AstraZeneca; Celgene; Lilly; NanoString Technologies; Novartis; Roche |
Consulting or Advisory Role - Accelsiors |
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Ipsen; Lilly; Medtronic; Novartis; Pfizer |
|
|
Honoraria - Amgen; AstraZeneca; Lilly; Novartis; Pfizer |
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; Pfizer |
Travel, Accommodations, Expenses - Amgen; Roche |
|
|
Honoraria - Amgen; AstraZeneca; Celgene; Lilly; Roche |
Consulting or Advisory Role - Amgen; AstraZeneca; Novartis; Pfizer; Roche |
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - Amgen |
|
|
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer |
Research Funding - AstraZeneca; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Celgene; Novartis; Pfizer; Roche |
Speakers' Bureau - Amgen; Celgene; Novartis; Pfizer; Pierre Fabre; Roche |
Research Funding - Amgen; Celgene |
Travel, Accommodations, Expenses - Celgene; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
Elisabeth Melbinger-Zeinitzer |
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Lilly |
|
|
|
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst) |
Other Relationship - UpToDate |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Celgene; Roche |
|
|
No Relationships to Disclose |
|
|
Research Funding - Amgen (Inst) |
|
|
Research Funding - Amgen (Inst) |
|
|
No Relationships to Disclose |